Neither the Satochi pill nor the blood sugar control ring advertised as a diabetes treatment have been approved by the FDA. | Tech Reddy


Update (November 1, 2022):

Another blood sugar monitor product is being sold through a Facebook page. Post says it’s a blood sugar control ring that uses magnetic acupressure therapy to stimulate the pancreas to promote insulin production. Let’s examine this claim.

Acupressure is an ancient alternative medical treatment. To understand if there is any evidence to prove the effectiveness of this product in controlling blood sugar levels, we searched the internet with relevant keywords. In an AFP fact-check on blood sugar control rings, Dr. Sudeepa Sarkar said the product “is not FDA (US Food and Drug Administration) approved.”

Robert Gabbay, chief scientific and medical officer of the American Diabetes Association, said: “I’m not aware of any evidence or way that such a ring can help people control their blood glucose. It’s unfortunate that claims like these exist, and they distract people from more effective evidence-based treatments. Talking to your healthcare professional about a treatment plan for you should be your first step in controlling your blood glucose. Gabbay said.

The FDA has warned people to beware of illegal diabetes treatments. They posted a warning on their website. Consumers do not use such products for many reasons. For example, they may contain harmful ingredients or they may be purchased as over-the-counter products. Illegally sold products pose an additional risk if they cause people to delay or stop diabetes treatment. Without proper disease management, people with diabetes are at greater risk for developing serious health complications.’ The full advisory can be read here.

In conclusion, the FDA has not approved a blood sugar control ring for the treatment of diabetes.

Published (27 October 2022):

A post with an advertising video of a product named Satoshi is being shared on social networks. According to the video, it is an effervescent pill that improves insulin levels naturally.

Claim: Satoshi, a tablet advertised as a treatment for diabetes, has been approved by the FDA (Food and Drug Administration).

Fact: The United States Food and Drug Administration (FDA) is responsible for protecting public health by regulating human drugs and biological products, among a variety of other products, devices, and drugs. Satochi, the tablet advertised through viral mail, is not FDA approved. Hence the claim made in the post FALSE.

We clicked on the order link provided in the post and went to the website where we can buy the Satochi tablet. The product is said to be a nutritional supplement solution for stabilizing blood sugar. The website states that Satoshi is licensed and approved by the FDA. It also includes three different certifications as evidence, but none of them mentions the FDA.

According to the certificates, the company’s name is Lallemand –SALUTAGUSE PÄRMITEHAS AS, a Canadian company that produces yeast and bacteria, according to its website. The Lallemand pharma wing owns the rights to a drug called PMBL® sublingual tablets. We couldn’t find details of the Satochi tablet on their website.

The United States Food and Drug Administration (FDA) is responsible for protecting public health by regulating human drugs and biological products, among a variety of other products, devices, and drugs. The FDA’s website has a database of approved drugs and Satoshi Tablet is not on their list of approved drugs. This means that, as the viral post suggests, Satoshi has not yet been approved by the FDA. According to the FDA website, ‘New drugs and biological products for humans must be approved by the FDA before they can be sold in interstate commerce. This means that a company must demonstrate that its drug or biological product is safe and effective for its intended use and that it can manufacture the product in accordance with federal quality standards..’

The FDA’s website also states “but not all of these products (human drugs, biologics, etc.) go through premarketing—that is, a safety, quality, and efficacy review by FDA experts and agency approval before the product is sold to consumers. In some cases, FDA enforcement actions have focused on products after they have been marketed. This is determined by the Congress in its creation FDA authorities. Although FDA approval is not required before a product can be marketed, the agency has statutory regulatory authority to act when safety concerns arise.According to the FDA, a manufacturer may use the phrase ‘FDA approved’ as part of its labeling or in advertising only after receiving a letter of approval for the product. Click here to learn more about the FDA’s drug development and approval process.

In conclusion, the Satochi pill, which is recommended for the treatment of diabetes, is not approved by the FDA.



Source link